Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHAPE Gel in Alopecia Areata
NCT02636244Phase 2Unknown
- Sponsor
- TetraLogic Pharmaceuticals
- Start
- Feb 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of remetinostat in alopecia areata, sponsored by TetraLogic Pharmaceuticals. Status: unknown.
02
Drugs
remetinostat
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02636244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636244.